Multiple lipid-metabolism and signaling pathways

Multiple lipid-metabolism and signaling pathways refer to the integrated network of biochemical reactions and signaling cascades involved in the synthesis, transport, and degradation of lipids such as cholesterol, triglycerides, and phospholipids (National Center for Biotechnology Information, 2023). These pathways encompass the exogenous and endogenous lipid transport systems, fatty acid beta-oxidation, and the synthesis of bile acids, which are essential for maintaining cellular membrane integrity and energy balance (StatPearls, 2023). Key molecular components within these pathways include enzymes like HMG-CoA reductase, nuclear receptors such as Peroxisome Proliferator-Activated Receptors (PPARs), and signaling molecules like sphingosine-1-phosphate (Nature Reviews Molecular Cell Biology, 2020). Dysregulation of these pathways is a central driver in the pathogenesis of metabolic disorders, including atherosclerosis, obesity, and non-alcoholic fatty liver disease (PubMed, 2022). Pharmacological interventions typically target specific nodes within these pathways, such as using statins to inhibit cholesterol synthesis or fibrates to enhance fatty acid oxidation (Journal of Lipid Research, 2021). Because this term describes a broad collection of biological processes rather than a single molecular entity, it is classified as a pathway group rather than a discrete therapeutic target.

Other names

Lipid metabolismLipid signalingLipid homeostasis pathwaysLipid metabolic processes

Drugs targeting these pathways act through diverse mechanisms including the inhibition of rate-limiting enzymes (e.g., HMG-CoA reductase), activation of nuclear receptors (e.g., PPARs), and modulation of lipoprotein clearance or absorption (StatPearls, 2023).